Top compounds associated with response to RRP9


Feature Type Standardized
Nominal ANOVA
mRNA pac-1 GDSC1000 pan-cancer AAC 0.079 0.03
mRNA paclitaxel gCSI pan-cancer AAC 0.11 0.03
mRNA triptolide CTRPv2 pan-cancer AAC 0.077 0.03
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.069 0.03
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.066 0.04
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.072 0.04
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.1 0.04
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.04
Download CSV